| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99215 |
Prolong outpt/office vis |
9,221 |
8,248 |
$388K |
| 96367 |
|
926 |
447 |
$43K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,910 |
1,001 |
$35K |
| 99417 |
Prolong home eval add 15m |
507 |
488 |
$20K |
| 96415 |
|
610 |
312 |
$12K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
209 |
209 |
$10K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
699 |
396 |
$8K |
| 99233 |
Prolong inpt eval add15 m |
135 |
24 |
$6K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
231 |
153 |
$6K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
335 |
149 |
$5K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
371 |
163 |
$3K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
84 |
81 |
$1K |
| 99223 |
Prolong inpt eval add15 m |
15 |
14 |
$960.40 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
863 |
418 |
$920.82 |
| 99354 |
|
12 |
12 |
$632.50 |
| 96417 |
|
16 |
12 |
$428.85 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
46 |
12 |
$269.78 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
221 |
102 |
$2.40 |